C21 Investments Inc.

C21 Investments Inc. filed its annual financial statements for the years ended March 31, 2026 and 2025. The company reported an increase in revenue to $32.61 million and a reduced net loss of $3.24 million for FY2026. However, total assets and shareholders' equity saw a decrease. The filing also notes the recent rescheduling of marijuana to Schedule III by the DEA and the company's ongoing assessment of its impact.